Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study
Xuehan Shen,* Tianyin Shao,* Jun Yu, Zhiwei Zhang Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China*These authors contributed equally to this workCorrespondence...
Saved in:
| Main Authors: | Shen X, Shao T, Yu J, Zhang Z |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/combining-hepatic-arterial-interventional-therapies-with-lenvatinib-an-peer-reviewed-fulltext-article-JHC |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
by: Yuki Ohya, et al.
Published: (2020-12-01) -
Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
by: Li X, et al.
Published: (2025-01-01) -
Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis
by: Kun-Ming Chan, et al.
Published: (2025-04-01) -
A Rare Case of Portal Vein Thrombosis Due to Portal Vein Aneurysm. Case Report and the Review of the Literature
by: J. Arudchelvam
Published: (2024-12-01) -
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
by: Liu CW, et al.
Published: (2025-05-01)